Jan 9 2026

 Market Tone:

Volatile, headline-driven. Defense stocks rebounded after Trump proposed a $1.5T FY27 defense budget (vs. ~$1T prior), despite earlier pressure over buybacks/dividends. Expect whipsaw action to continue.

Key Gainers / Watchlist:

• Defense: LMT, NOC, GD – rebound on budget optimism; trade headlines, not fundamentals today.

• Bloom Energy (BE): Big gap up on $2.6–$5B AEP fuel-cell deal + Wyoming facility.

• Globus Medical (GMED): Gapping higher after raised Q4 sales and 2026 outlook.

• Applied Digital (APLD): Revenue +98%, hyperscaler talks → AI/data-center momentum.

• Memory Semis: Samsung earnings nearly tripled → sympathy moves in memory names.

M&A / Corporate Action:

• Eli Lilly (LLY): Confirmed Ventex buyout ($14/share); VTYX largely priced in.

• CrowdStrike (CRWD): Buying AI identity startup CGNL (~$740M).

• AbbVie (ABBV): Denies talks with RVMD → RVMD likely to fade.

Weak / Risk Areas:

• Biotech: IMRX collapsing on failed Phase 2B data.

• Solar: CSIQ down on $200M convertible offering.

• Financials: JEF pressured by GAAP miss tied to First Brands charge.

Consumer & Macro Reads:

• Costco (COST): Strong December comps, but trend still weak → watch for bounce vs. fade.

• China / NVDA: Reports China may approve H200 purchases this quarter → headline sensitivity remains.

Today’s Focus:
Trade gaps and reversals, watch defense for policy volatility, and AI/data-center names for momentum continuation